INTERNATIONAL PATENT: RESOLVE THERAPEUTICS, LLC FILES APPLICATION FOR "TREATMENT OF SYMPTOMS ASSOCIATED WITH SARS-COV VIRAL INFECTION OR A PRIOR SARS-COV VIRAL INFECTION WITH NUCLEASE AGENTS"

GENEVA, July 14 -- RESOLVE THERAPEUTICS, LLC (1951 NW 7th AveSuite 300Miami, Florida 33136) filed a patent application (PCT/US2025/010402) for "TREATMENT OF SYMPTOMS ASSOCIATED WITH SARS-COV VIRAL INFECTION OR A PRIOR SARS-COV VIRAL INFECTION WITH NUCLEASE AGENTS" on Jan 06, 2025. With publication no. WO/2025/147696, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POSADA, James Arthur (460 NE 28th St, Unit 1504Miami, Florida 33137)

Abstract: The present disclosure provides methods for treating symptoms (e.g., fatigue, ...